
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Call for Standardization of C-Peptide Measurement - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FF20820E89B737231A820E00393C550E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jdst">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Diabetes Science and Technology">
<meta name="citation_title" content="Call for Standardization of C-Peptide Measurement">
<meta name="citation_author" content="Erwin Schleicher">
<meta name="citation_author_institution" content="Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany">
<meta name="citation_author_institution" content="Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tuebingen, Tuebingen, Germany">
<meta name="citation_author" content="Kuanysh Kabytaev">
<meta name="citation_author_institution" content="Departments of Pathology &amp; Anatomical Sciences and Child Health, University of Missouri School of Medicine, Columbia, MO, USA">
<meta name="citation_author" content="Matthias Nauck">
<meta name="citation_author_institution" content="Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsmedizin Greifswald, Greifswald/DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine Greifswald, Greifswald, Germany">
<meta name="citation_author" content="Dirk Müller-Wieland">
<meta name="citation_author_institution" content="Medical Clinic I, RWTH Aachen University, Germany, Aachen">
<meta name="citation_author" content="Andreas Peter">
<meta name="citation_author_institution" content="Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany">
<meta name="citation_author_institution" content="Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tuebingen, Tuebingen, Germany">
<meta name="citation_author_institution" content="German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany">
<meta name="citation_author" content="Randie R Little">
<meta name="citation_author_institution" content="Departments of Pathology &amp; Anatomical Sciences and Child Health, University of Missouri School of Medicine, Columbia, MO, USA">
<meta name="citation_author" content="Lutz Heinemann">
<meta name="citation_author_institution" content="Science Consulting in Diabetes GmbH, Düsseldorf, Germany">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_firstpage" content="19322968251362848">
<meta name="citation_doi" content="10.1177/19322968251362848">
<meta name="citation_pmid" content="40781799">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/pdf/10.1177_19322968251362848.pdf">
<meta name="description" content="An impaired β-cell function is a key contributor to the pathophysiology of diabetes mellitus that can be estimated by the biomarker C-peptide. Measurement of C-peptide can therefore be used for prediction, diagnosis, and subclassification of ...">
<meta name="og:title" content="Call for Standardization of C-Peptide Measurement">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="An impaired β-cell function is a key contributor to the pathophysiology of diabetes mellitus that can be estimated by the biomarker C-peptide. Measurement of C-peptide can therefore be used for prediction, diagnosis, and subclassification of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12335430">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1177/19322968251362848"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/10.1177_19322968251362848.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12335430%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12335430/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12335430/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jdst.png" alt="Journal of Diabetes Science and Technology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Diabetes Science and Technology" title="Link to Journal of Diabetes Science and Technology" shape="default" href="https://doi.org/10.1177/19322968251362848" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Diabetes Sci Technol</button></div>. 2025 Aug 8:19322968251362848. Online ahead of print. doi: <a href="https://doi.org/10.1177/19322968251362848" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1177/19322968251362848</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Diabetes%20Sci%20Technol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Diabetes%20Sci%20Technol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Diabetes%20Sci%20Technol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Diabetes%20Sci%20Technol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Call for Standardization of C-Peptide Measurement</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schleicher%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Erwin Schleicher</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Erwin Schleicher</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany</div>
<div class="p">
<sup>2</sup>Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tuebingen, Tuebingen, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schleicher%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Erwin Schleicher</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kabytaev%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kuanysh Kabytaev</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Kuanysh Kabytaev</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>3</sup>Departments of Pathology &amp; Anatomical Sciences and Child Health, University of Missouri School of Medicine, Columbia, MO, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kabytaev%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kuanysh Kabytaev</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nauck%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Matthias Nauck</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Matthias Nauck</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>4</sup>Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsmedizin Greifswald, Greifswald/DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine Greifswald, Greifswald, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nauck%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matthias Nauck</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCller-Wieland%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Dirk Müller-Wieland</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Dirk Müller-Wieland</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>5</sup>Medical Clinic I, RWTH Aachen University, Germany, Aachen</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCller-Wieland%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dirk Müller-Wieland</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peter%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Andreas Peter</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Andreas Peter</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>1</sup>Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany</div>
<div class="p">
<sup>2</sup>Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tuebingen, Tuebingen, Germany</div>
<div class="p">
<sup>6</sup>German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peter%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andreas Peter</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Little%20RR%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Randie R Little</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Randie R Little</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>3</sup>Departments of Pathology &amp; Anatomical Sciences and Child Health, University of Missouri School of Medicine, Columbia, MO, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Little%20RR%22%5BAuthor%5D" class="usa-link"><span class="name western">Randie R Little</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heinemann%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lutz Heinemann</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Lutz Heinemann</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>7</sup>Science Consulting in Diabetes GmbH, Düsseldorf, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heinemann%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lutz Heinemann</span></a>
</div>
</div>
<sup>7</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1-19322968251362848">
<sup>1</sup>Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany</div>
<div id="aff2-19322968251362848">
<sup>2</sup>Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, University of Tuebingen, Tuebingen, Germany</div>
<div id="aff3-19322968251362848">
<sup>3</sup>Departments of Pathology &amp; Anatomical Sciences and Child Health, University of Missouri School of Medicine, Columbia, MO, USA</div>
<div id="aff4-19322968251362848">
<sup>4</sup>Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsmedizin Greifswald, Greifswald/DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine Greifswald, Greifswald, Germany</div>
<div id="aff5-19322968251362848">
<sup>5</sup>Medical Clinic I, RWTH Aachen University, Germany, Aachen</div>
<div id="aff6-19322968251362848">
<sup>6</sup>German Center for Diabetes Research (DZD E.V.), Neuherberg, Germany</div>
<div id="aff7-19322968251362848">
<sup>7</sup>Science Consulting in Diabetes GmbH, Düsseldorf, Germany</div>
<div class="author-notes p"><div class="fn" id="corresp1-19322968251362848">
<sup>✉</sup><p class="display-inline">Erwin Schleicher, PhD, Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Hoppe-Seylerstr. 3, Tuebingen 7276, Germany. Email: <span>erwin.schleicher@med.uni-tuebingen.de</span></p>
</div></div>
</div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Diabetes Technology Society</div>
<p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc/4.0/</a>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<a href="https://us.sagepub.com/en-us/nam/open-access-at-sage" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://us.sagepub.com/en-us/nam/open-access-at-sage</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12335430  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40781799/" class="usa-link">40781799</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="section1-19322968251362848"><h3 class="pmc_sec_title">Background:</h3>
<p>An impaired β-cell function is a key contributor to the pathophysiology of diabetes mellitus that can be estimated by the biomarker C-peptide. Measurement of C-peptide can therefore be used for prediction, diagnosis, and subclassification of diabetes. Furthermore, C-peptide assists in the prediction of therapeutic response and guiding therapeutic decisions. To support diabetes classification, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have recently introduced serum C-peptide cut-off values in their guidelines: &lt;0.2 nmol/L C-peptide levels suggest the presence of type 1 DM while C-peptide levels &gt;0.6 nmol/L indicate type 2 DM. However, analytical aspects limit the clinical utility of these defined cut-off values since standardization of C-peptide measurements has not been achieved. Results from different assay manufacturers still show significant variability.</p></section><section id="section2-19322968251362848"><h3 class="pmc_sec_title">Results:</h3>
<p>This discrepancy can have significant consequences, as reliance on C-peptide testing for diabetes classification and therapeutic decisions has steadily increased in recent years. Although there have been growing calls to standardize C-peptide testing and a process for standardization has been established, standardization has unfortunately yet to be implemented in practice.</p></section><section id="section3-19322968251362848"><h3 class="pmc_sec_title">Conclusion:</h3>
<p>It therefore seems appropriate for health care providers to advocate for standardized C-peptide measurements, which is more or less in the hands of the manufacturer of the C-peptide assays, to improve diagnostic accuracy and patient safety.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> C-peptide, insulin measurement, diabetes diagnosis, prediabetes</p></section></section><section id="section4-19322968251362848"><h2 class="pmc_sec_title">Introduction</h2>
<p>Besides clinical presentation, the diagnosis and management of diabetes mellitus (DM) are essentially based on laboratory measures of hyperglycemia, such as plasma glucose and HbA<sub>1c</sub>.<sup><a href="#bibr1-19322968251362848" class="usa-link" aria-describedby="bibr1-19322968251362848">1</a>,<a href="#bibr2-19322968251362848" class="usa-link" aria-describedby="bibr2-19322968251362848">2</a></sup> However, due to the complex nature of diabetes pathogenesis, relying solely on these biomarkers does not allow for a clear distinction between the different forms and presentations of DM, potentially leading to misdiagnosis and inappropriate therapy.<sup>
<a href="#bibr3-19322968251362848" class="usa-link" aria-describedby="bibr3-19322968251362848">3</a>
</sup> Recent American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) guidelines have begun to recommend the use of C-peptide testing to more accurately distinguish between type 1, type 2, and monogenic forms of diabetes, particularly in cases where the diagnosis is uncertain.<sup><a href="#bibr1-19322968251362848" class="usa-link" aria-describedby="bibr1-19322968251362848">1</a>,<a href="#bibr4-19322968251362848" class="usa-link" aria-describedby="bibr4-19322968251362848">4</a>,<a href="#bibr5-19322968251362848" class="usa-link" aria-describedby="bibr5-19322968251362848">5</a></sup> A diagnostic flowchart has been proposed that incorporates two C-peptide cut-off values—0.2 nmol/L and 0.6 nmol/L—along with patient age, clinical features, and islet autoantibody testing. The proposed diagnostic thresholds are limited to a white European adult population. There is less knowledge for non-European/different ethnic populations. A previous publication indicates that even the populations of people with diabetes in China and India are different in β-cell function and insulin resistance, respectively.<sup>
<a href="#bibr6-19322968251362848" class="usa-link" aria-describedby="bibr6-19322968251362848">6</a>
</sup></p>
<p>Increasing evidence demonstrates the role of C-peptide as a valuable metric for the subclassification of type 2 diabetes. Considering its heterogeneous nature, C-peptide has the potential to enable more personalized diagnostic and treatment approaches.<sup><a href="#bibr7-19322968251362848" class="usa-link" aria-describedby="bibr7-19322968251362848">7</a>-<a href="#bibr9-19322968251362848" class="usa-link" aria-describedby="bibr9-19322968251362848">9</a></sup></p>
<p>In clinical laboratories, C-peptide measurement is typically performed using immunoassays. Although each assay is factory-calibrated using its own proprietary scheme, they share a common feature: calibration with synthetic, purified C-peptide material. Currently, two versions of this material are available, both provided by the World Health Organization (WHO). However, concerns remain about discrepancies among different measurements, as true standardization of the C-peptide assay has never been achieved.<sup><a href="#bibr9-19322968251362848" class="usa-link" aria-describedby="bibr9-19322968251362848">9</a>,<a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a></sup> Therefore, there is an urgent need for global standardization of C-peptide measurements. This can be driven by regulatory bodies; however, it has to be implemented by the manufacturer of the C-peptide assays.</p></section><section id="section5-19322968251362848"><h2 class="pmc_sec_title">Background</h2>
<p>As mentioned previously, the clinical presentation of a person with diabetes does not always allow a proper classification of DM. Therefore, considering the disease’s pathogenesis may help to classify the patient’s type of diabetes and therefore lead to adequate therapy. Different pathophysiological mechanisms can lead to chronically elevated glucose levels. These include:</p>
<ol id="list1-19322968251362848" class="list" style="list-style-type:decimal">
<li><p>A reduced or absent ability of the β-cell to secrete insulin, as seen in persons with type 1 diabetes mellitus (T1DM) or cases caused by genetic defects, such as maturity-onset diabetes of the young (MODY).<sup><a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a>,<a href="#bibr11-19322968251362848" class="usa-link" aria-describedby="bibr11-19322968251362848">11</a></sup></p></li>
<li><p>Decreased insulin action due to insulin resistance, often accompanied by a progressive decline in insulin secretion over time,<sup>
<a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>
</sup> or</p></li>
<li><p>A less well-defined form of diabetes is known as latent autoimmune diabetes in adults (LADA).<sup><a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a>,<a href="#bibr12-19322968251362848" class="usa-link" aria-describedby="bibr12-19322968251362848">12</a></sup></p></li>
</ol>
<p>Therefore, in addition to the clinical presentation of individuals with diabetes, assessing β-cell responsiveness in relation to their nutritional and metabolic status may support more accurate characterization and subsequently facilitate the optimization of diabetes treatment.<sup>
<a href="#bibr13-19322968251362848" class="usa-link" aria-describedby="bibr13-19322968251362848">13</a>
</sup></p></section><section id="section6-19322968251362848"><h2 class="pmc_sec_title">Estimation of β-Cell Function</h2>
<p>Insulin and C-peptide are produced in the pancreatic β-cells by proteolytic cleavage of preformed proinsulin. Upon stimulation, insulin and C-peptide are secreted into the bloodstream in a 1:1 molar ratio. Therefore, both physiological peptides are the only measures reflecting the β-cell capacity and function. Other laboratory parameters like HbA<sub>1c</sub>, acute blood glucose levels or continuous glucose monitor (CGM) data are indirect indicators of β-cell capacity and function. Since insulin is the biologically active hormone earlier studies measured blood insulin levels for metabolic studies. However, previous studies have indicated that the determination of insulin has several disadvantages. Since insulin is rapidly cleared by the liver, only a variable percentage (typically 50% or less) reaches the peripheral circulation from which blood samples are taken.<sup>
<a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>
</sup> In contrast, C-peptide is cleared in the kidney at a lower and more constant rate resulting in peripheral concentrations that are more than five times higher than those of insulin.<sup>
<a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>
</sup> Furthermore, insulin values cannot be reliably interpreted in insulin-treated patients, as commonly used assays detect both endogenous and exogenous insulin to varying extents. Therefore, most recent studies have adopted C-peptide as a surrogate marker of β-cell function.<sup><a href="#bibr14-19322968251362848" class="usa-link" aria-describedby="bibr14-19322968251362848">14</a>-<a href="#bibr16-19322968251362848" class="usa-link" aria-describedby="bibr16-19322968251362848">16</a></sup></p>
<p>For unequivocal determination of β-cell function and β-cell capacity, the release of C-peptide is determined under-stimulated and non-stimulated conditions. While fasting C-peptide levels indicate basal status, stimulation tests may detect the residual beta-cell capacity for insulin secretion. The glucagon stimulation test (GST), mixed-meal tolerance test (MMTT), and oral glucose tolerance test (oGTT) are widely used in both clinical practice and research to evaluate β-cell functional capacity under-stimulated conditions.<sup>
<a href="#bibr17-19322968251362848" class="usa-link" aria-describedby="bibr17-19322968251362848">17</a>
</sup> The GST is based on the action of glucagon (1 mg i.v.), which rapidly stimulates the secretion of insulin and C-peptide. Determination of the C-peptide value after 6 minutes reflects β-cell function and capacity, as glucagon-induced stimulation is independent of glucose and other metabolically active hormones.<sup>
<a href="#bibr17-19322968251362848" class="usa-link" aria-describedby="bibr17-19322968251362848">17</a>
</sup> Although this test is invasive and may cause nausea, the GST is considered superior to glucose-induced stimulation, particularly because it is more reproducible and more sensitive. Since the MMTT also shows high specificity and excellent sensitivity, both tests are recommended for the assessment of β-cell function.<sup>
<a href="#bibr18-19322968251362848" class="usa-link" aria-describedby="bibr18-19322968251362848">18</a>
</sup></p></section><section id="section7-19322968251362848"><h2 class="pmc_sec_title">Clinical Utility of C-Peptide Determination</h2>
<p>Until recently, C-peptide measurement was viewed primarily as a research tool with limited relevance in clinical practice. However, numerous reports indicate the potential utility of C-peptide in various clinical situations. These include:</p>
<p>Prognosis:</p>
<ul id="list2-19322968251362848" class="list" style="list-style-type:none">
<li><p>Prediction of DM onset.<sup>
<a href="#bibr19-19322968251362848" class="usa-link" aria-describedby="bibr19-19322968251362848">19</a>
</sup></p></li>
<li><p>Detection of β-cell dysfunction prior to the manifestation of type 1 diabetes.<sup><a href="#bibr20-19322968251362848" class="usa-link" aria-describedby="bibr20-19322968251362848">20</a>,<a href="#bibr21-19322968251362848" class="usa-link" aria-describedby="bibr21-19322968251362848">21</a></sup></p></li>
<li><p>Monitoring the preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes.<sup>
<a href="#bibr22-19322968251362848" class="usa-link" aria-describedby="bibr22-19322968251362848">22</a>
</sup></p></li>
</ul>
<p>Diagnosis and classification:</p>
<ul id="list3-19322968251362848" class="list" style="list-style-type:none">
<li><p>Differentiation of diabetes types.<sup><a href="#bibr23-19322968251362848" class="usa-link" aria-describedby="bibr23-19322968251362848">23</a>-<a href="#bibr26-19322968251362848" class="usa-link" aria-describedby="bibr26-19322968251362848">26</a></sup></p></li>
<li><p>Supporting sub-classification of DM.<sup><a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a>,<a href="#bibr27-19322968251362848" class="usa-link" aria-describedby="bibr27-19322968251362848">27</a></sup></p></li>
<li><p>Patient clustering based on novel classifications.<sup><a href="#bibr7-19322968251362848" class="usa-link" aria-describedby="bibr7-19322968251362848">7</a>,<a href="#bibr28-19322968251362848" class="usa-link" aria-describedby="bibr28-19322968251362848">28</a></sup></p></li>
</ul>
<p>Therapeutic utility:</p>
<ul id="list4-19322968251362848" class="list" style="list-style-type:none">
<li><p>Guiding therapeutic decisions.<sup><a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>,<a href="#bibr16-19322968251362848" class="usa-link" aria-describedby="bibr16-19322968251362848">16</a></sup></p></li>
<li><p>Predicting therapeutic responses.<sup><a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a>,<a href="#bibr29-19322968251362848" class="usa-link" aria-describedby="bibr29-19322968251362848">29</a></sup></p></li>
<li><p>Management of glucose control.<sup><a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>,<a href="#bibr16-19322968251362848" class="usa-link" aria-describedby="bibr16-19322968251362848">16</a>,<a href="#bibr25-19322968251362848" class="usa-link" aria-describedby="bibr25-19322968251362848">25</a>,<a href="#bibr30-19322968251362848" class="usa-link" aria-describedby="bibr30-19322968251362848">30</a>-<a href="#bibr32-19322968251362848" class="usa-link" aria-describedby="bibr32-19322968251362848">32</a></sup></p></li>
<li><p>Adjusting or supplementing therapy with alternative drugs.<sup><a href="#bibr33-19322968251362848" class="usa-link" aria-describedby="bibr33-19322968251362848">33</a>,<a href="#bibr34-19322968251362848" class="usa-link" aria-describedby="bibr34-19322968251362848">34</a></sup></p></li>
</ul>
<p>Prediction of vascular complications:</p>
<ul id="list5-19322968251362848" class="list" style="list-style-type:none">
<li><p>Risk stratification for microvascular and macrovascular complications.<sup><a href="#bibr10-19322968251362848" class="usa-link" aria-describedby="bibr10-19322968251362848">10</a>,<a href="#bibr25-19322968251362848" class="usa-link" aria-describedby="bibr25-19322968251362848">25</a></sup></p></li>
<li><p>Prediction of cardiovascular mortality.<sup>
<a href="#bibr35-19322968251362848" class="usa-link" aria-describedby="bibr35-19322968251362848">35</a>
</sup></p></li>
</ul></section><section id="section8-19322968251362848"><h2 class="pmc_sec_title">Examples of Decision-Making in the Therapy of Diabetes</h2>
<p>While many studies do not report details regarding C-peptide measurement, a review by Jones and Hattersley summarizes findings from clinical studies on the diagnostic and therapeutic utility of C-peptide, including proposed cut-off values.<sup>
<a href="#bibr23-19322968251362848" class="usa-link" aria-describedby="bibr23-19322968251362848">23</a>
</sup> For example, the authors conclude that in insulin-treated individuals with diabetes, a fasting C-peptide value of &lt;0.25 nmol/L or a stimulated C-peptide level of &lt;0.6 nmol/L suggests marked insulin deficiency and is indicative of type 1 diabetes. Although numerous studies propose cut-off values, there is considerable variation in their optimal thresholds and predictive power. These discrepancies may reflect differences in patient populations, stimulation methods, or C-peptide assay techniques. In addition, a previous report proposed the use of the C-peptide/glucose ratio (CGR; pmol/mg/dL) to guide treatment decisions in people with diabetes.<sup>
<a href="#bibr8-19322968251362848" class="usa-link" aria-describedby="bibr8-19322968251362848">8</a>
</sup> Based on data from a well-characterized diabetic cohort (n = 330), the authors recommend the following CGR-based approach:</p>
<ul id="list6-19322968251362848" class="list" style="list-style-type:disc">
<li><p>CGR &lt;2: insulin therapy is required.</p></li>
<li><p>2 ≤CGR &lt;5: Basal insulin combined with antihyperglycemic agents is recommended.</p></li>
<li><p>CGR ≥5: Insulin therapy is not necessary.</p></li>
</ul>
<p>Furthermore, for patients with CGR ≥2 and elevated cardiovascular risk, SGLT2 inhibitors or GLP-1 receptor agonists are the preferred treatment option. The authors conclude that these therapeutic recommendations rely on the accurate and precise determination of the CGR and are only valid if the C-peptide results are comparable between clinical chemistry laboratories.</p>
<p>In summary, these reports demonstrate the multiple utilities of C-peptide in the clinical setting including prognosis, diagnosis and classification, therapeutic management, and the prediction of vascular complications in prediabetic individuals and individuals with diabetes. Ultimately, these applications need to be validated through prospective clinical trials.</p></section><section id="section9-19322968251362848"><h2 class="pmc_sec_title">C-Peptide as a Marker of β-Cell Dysfunction in Clinical Trials</h2>
<p>Studies have shown that stimulated C-peptide gradually decreases before the clinical diagnosis of type 1 diabetes.<sup><a href="#bibr20-19322968251362848" class="usa-link" aria-describedby="bibr20-19322968251362848">20</a>,<a href="#bibr36-19322968251362848" class="usa-link" aria-describedby="bibr36-19322968251362848">36</a></sup> The TrialNet study examined the longitudinal changes of C-peptide and metabolic parameters from preclinical stages through and beyond clinical diagnosis.<sup>
<a href="#bibr37-19322968251362848" class="usa-link" aria-describedby="bibr37-19322968251362848">37</a>
</sup> C-peptide decline becomes significant approximately six months before diagnosis and continues to decline for about a year after diagnosis. In these studies, stimulated C-peptide values were typically expressed as the area under the curve (AUC), measured over a 2-hour period. The preference for AUC response over time, rather than single time-point measurements, is due to its ability to capture the total C-peptide response. Previous studies have demonstrated that AUC provides more consistent results than fasting C-peptide, establishing the MMTT AUC as the gold standard for assessing beta-cell function.<sup>
<a href="#bibr38-19322968251362848" class="usa-link" aria-describedby="bibr38-19322968251362848">38</a>
</sup> For data analysis, C-peptide data is typically log-transformed due to its skewed distribution and lack of normality, which can complicate the interpretability of C-peptide concentrations. At the same time, epidemiologists continue to develop more advanced models. For example, the recently proposed Quantitative Response (QR) model incorporates not only C-peptide but also additional confounding factors, aiming to more accurately reflect beta-cell secretion.<sup>
<a href="#bibr39-19322968251362848" class="usa-link" aria-describedby="bibr39-19322968251362848">39</a>
</sup> These approaches are methodologically distinct from earlier studies, such as the landmark DCCT study, which considered only fasting or single-point stimulated C-peptide concentrations (at 90 minutes).<sup>
<a href="#bibr40-19322968251362848" class="usa-link" aria-describedby="bibr40-19322968251362848">40</a>
</sup> All these changes in C-peptide metrics are aimed at better capturing the pathophysiological changes in type 1 diabetes progression.</p>
<p>C-peptide is increasingly recognized as a prognostic marker, especially with recent advancements in disease-modifying therapies for type 1 diabetes. Thus, a meta-analysis of 21 immunotherapy trials provides strong evidence supporting C-peptide levels as a reliable surrogate endpoint.<sup>
<a href="#bibr41-19322968251362848" class="usa-link" aria-describedby="bibr41-19322968251362848">41</a>
</sup> In all studies, β-cell function was assessed using the meal-stimulated AUC of C-peptide, involving a total of 1315 adults (≥18 years) and 1396 children (&lt;18 years) with type 1 diabetes. This expanded participant pool increases the statistical power of the analysis, offering more definitive evidence compared to previous studies. The improvements in HbA<sub>1c</sub> are directly proportional to the extent of C-peptide preservation. A 55% preservation of C-peptide is associated with a 0.64% reduction in HbA<sub>1c</sub>, while maintaining 76% of initial C-peptide levels enables nearly all participants to achieve optimal glycemic targets. A recent study compiling results from large clinical trials, including DCCT, Epidemiology of Diabetes Interventions and Complications (EDIC), Scottish Diabetes Research Network Type 1 Bioresource (SDRNT1BIO), and Collaborative Islet Transplant Registry (CITR), supports the use of C-peptide as a measurable endpoint alongside widely accepted outcomes such as reductions in HbA<sub>1c</sub> and microvascular complications for disease-modifying therapies.<sup>
<a href="#bibr29-19322968251362848" class="usa-link" aria-describedby="bibr29-19322968251362848">29</a>
</sup> C-peptide may offer advantages in modern trials over other endpoints, as hypoglycemia is less of a concern with CGM in place, HbA<sub>1c</sub> levels often remain below 7% during the first year of stage 3 type 1 diabetes, and microvascular complications take a long time to develop.<sup>
<a href="#bibr42-19322968251362848" class="usa-link" aria-describedby="bibr42-19322968251362848">42</a>
</sup></p>
<p>The Food and Drug Administration (FDA) approval process for new immunotherapies is time-consuming, and without clear benefits, progress can be stalled. As a result, teplizumab, the first successful agent for individuals in stage 2 of type 1 diabetes, has only recently advanced to stage 2 of the regulatory process.<sup>
<a href="#bibr43-19322968251362848" class="usa-link" aria-describedby="bibr43-19322968251362848">43</a>
</sup> This development can be seen not only as a golden opportunity for beta-cell preservation therapies but also as a pivotal moment for the broader adoption of C-peptide as a surrogate outcome in other studies.<sup>
<a href="#bibr44-19322968251362848" class="usa-link" aria-describedby="bibr44-19322968251362848">44</a>
</sup> It took time for C-peptide to gain acceptance as a surrogate marker in beta-cell preservation trials for assessing treatment efficacy and disease progression. However, epidemiological studies often prioritize a broader perspective over technical nuances, leading trial designs to overlook or insufficiently address the details of measurement procedures, such as C-peptide quantification. There is variability in assay selection, eligibility criteria based on C-peptide thresholds, and methodologies for endpoint determination. These inconsistencies in measurements, combined with some ambiguity in findings, may create challenges in interpretation for clinicians—particularly for practicing physicians who rely on a clear translation of trial results before definitive guidelines are established. As evidence of C-peptide utility continues to accumulate, further steps toward standardizing trial methodologies are expected, enhancing cross-study comparability and benefiting all stakeholders.</p>
<p>Why has C-peptide not yet been widely recognized as a biomarker comparable to HbA<sub>1c</sub>? In addition to the long adoption period that HbA<sub>1c</sub> has undergone, a key reason for its widespread acceptance is that it was clearly shown from the beginning to have clinical benefits. The DCCT study demonstrated that once HbA<sub>1c</sub> exceeded 6.5%, the likelihood of developing retinopathy in the following years increased rapidly.<sup>
<a href="#bibr45-19322968251362848" class="usa-link" aria-describedby="bibr45-19322968251362848">45</a>
</sup> This strong correlation between HbA<sub>1c</sub> and clinical outcomes and subsequent standardization of HbA<sub>1c</sub> has established HbA<sub>1c</sub> as an important endpoint in trials. In contrast, the longitudinal association of C-peptide with complications reflects a more gradual progression compared to HbA<sub>1c</sub>. As a result, interpreting models that incorporate C-peptide in clinical trials is more complex and requires a nuanced approach.</p></section><section id="section10-19322968251362848"><h2 class="pmc_sec_title">Limited Information on the C-Peptide Assay Used and the Validity of Obtained Values</h2>
<p>A systematic review including 515 publications found that C-peptide measurements were mentioned only in 32%, 54%, and 14% of type 1, type 2, and other specific diabetes types, respectively.<sup>
<a href="#bibr46-19322968251362848" class="usa-link" aria-describedby="bibr46-19322968251362848">46</a>
</sup> Only half of the studies specified the assay used, and few provided technical or analytical specifications of the C-peptide test. Data on measurement and variation of the C-peptide assay were mentioned only in 2% and 11% of the publications, respectively. In 22% of the reports, the C-peptide concentration was not even documented. A major problem of all these studies is the lack of C-peptide concentration, which may serve as a cut-off value, and essentially no information on the C-peptide assays used is provided. Therefore, it remains unclear if the different C-peptide values obtained for the various trials are due to different cohorts or due to the different assays used or both.</p></section><section id="section11-19322968251362848"><h2 class="pmc_sec_title">Reference Intervals</h2>
<p>Clinical chemistry laboratories are required to establish reference intervals for their methods, generally defined as the central 95% of laboratory values from a healthy population. A comparison of C-peptide reference intervals from multiple open sources reveals substantial inter-laboratory differences in C-peptide ranges (<a href="#table1-19322968251362848" class="usa-link">Table 1</a>). The lower limit of the reference interval ranges from 0.165 to 0.364 nmol/L, while the upper limit varies even more widely, ranging from 0.596 to 1.5 nmol/L for fasting C-peptide. Since some essential information is missing—such as sample material, the analytical method (assays used), and the cohort used to establish the reference ranges—it is difficult to determine whether the variability is due to biological or analytical factors, or both. Indeed, in this example, each laboratory could establish its own reference intervals tailored to the local population. However, the situation is not significantly better even for manufacturer-determined intervals. For instance, the ADVIA Centaur XPT and Immulite 2000 Xpi assays show a twofold difference at the high end—1.27 nmol/L vs. 2.35 nmol/L—which is surprising, given that both assays come from the same company and are calibrated using the same WHO reference material.<sup>
<a href="#bibr47-19322968251362848" class="usa-link" aria-describedby="bibr47-19322968251362848">47</a>
</sup></p>
<section class="tw xbox font-sm" id="table1-19322968251362848"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Examples of Fasting C-Peptide Reference Ranges (nmol/L) From Several Clinical Laboratories, According to Their Website.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="char" char="." span="1">
<col align="char" char="." span="1">
<col align="char" char="." span="1">
</colgroup>
<thead><tr>
<th align="center" rowspan="1" colspan="1">Laboratory</th>
<th align="center" rowspan="1" colspan="1">Range</th>
<th align="center" rowspan="1" colspan="1">(Sample material)</th>
<th align="center" rowspan="1" colspan="1">Method</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Cleveland Clinic</td>
<td rowspan="1" colspan="1">0.172–0.83<sup>
<a href="#table-fn2-19322968251362848" class="usa-link">a</a>
</sup>
</td>
<td rowspan="1" colspan="1">(n.i.)</td>
<td rowspan="1" colspan="1">n.i.</td>
</tr>
<tr>
<td rowspan="1" colspan="1">NIH</td>
<td rowspan="1" colspan="1">0.298–0.596</td>
<td rowspan="1" colspan="1">(n.i.)</td>
<td rowspan="1" colspan="1">n.i.</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Oxford Univ. Laboratory</td>
<td rowspan="1" colspan="1">&lt;0.08</td>
<td rowspan="1" colspan="1">(n.i.)</td>
<td rowspan="1" colspan="1">n.i.</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Bath</td>
<td rowspan="1" colspan="1">0.24–1.5</td>
<td rowspan="1" colspan="1">(P)</td>
<td rowspan="1" colspan="1">n.i.</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Rochester (New York)</td>
<td rowspan="1" colspan="1">0.165–0.894<sup>
<a href="#table-fn2-19322968251362848" class="usa-link">a</a>
</sup>
</td>
<td rowspan="1" colspan="1">(n.i.)</td>
<td rowspan="1" colspan="1">n.i.</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mayo Clinic (Pediatric)</td>
<td rowspan="1" colspan="1">0.364–1.456</td>
<td rowspan="1" colspan="1">(S)</td>
<td rowspan="1" colspan="1">Roche</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/table1-19322968251362848/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="table-fn1-19322968251362848"><p>Sample material: P = plasma, S = serum, n.i. = not indicated.</p></div>
<div class="fn" id="table-fn2-19322968251362848">
<sup>a</sup><p class="display-inline">Indicates a notice that test results may vary significantly from Laboratory to Laboratory.</p>
</div>
</div></section><p>Studies on C-peptide reference intervals are essential to support the broader adoption of C-peptide testing in clinical laboratories. Unfortunately, only a limited number of studies have established reference intervals for C-peptide. One such study focused on a Danish urban population, including 590 participants without diabetes.<sup>
<a href="#bibr48-19322968251362848" class="usa-link" aria-describedby="bibr48-19322968251362848">48</a>
</sup> The authors established two reference intervals for participants without prediabetes, based on WHO and ADA criteria, respectively: 0.376 to 1.479 nmol/L and 0.372 to 1.299 nmol/L. For all participants without diabetes, the interval was reported as 0.379 to 1.631 nmol/L. Fasting C-peptide levels were measured with the Cobas e411 analyzer (Roche Diagnostics). The authors acknowledge that the classification of individuals as without diabetes was based solely on fasting glucose and HbA<sub>1c</sub> levels, without a review of their medical records. Another study, conducted on the Korean population, included 1532 healthy, non-pregnant participants after excluding those with diseases based on their medical history.<sup>
<a href="#bibr49-19322968251362848" class="usa-link" aria-describedby="bibr49-19322968251362848">49</a>
</sup> For participants with HbA<sub>1c</sub> &lt;5.7% (the ADA criterion for prediabetes), the reference interval was 0.6 to 2.46 ng/mL (0.199-0.814 nmol/L) for fasting C-peptide and 2.2 to 10.39 ng/mL (0.728-3.440 nmol/L) for oGTT at 120 minutes, as measured by the Atellica IM from Siemens Healthcare Diagnostics.</p>
<p>In theory, a standardized assay can provide universal reference intervals if the reference population is well-defined and representative. This allows a reference interval, once established by the manufacturer, to be more easily adopted by different laboratories. Since conducting validation studies to determine reference intervals can be costly, requiring the enrollment of 120 participants, it is advantageous to utilize manufacturer-provided or published reference intervals instead of deriving new ones.<sup>
<a href="#bibr50-19322968251362848" class="usa-link" aria-describedby="bibr50-19322968251362848">50</a>
</sup> While laboratory verification may still be necessary, a smaller sample size of just 20 participants is sufficient.<sup>
<a href="#bibr51-19322968251362848" class="usa-link" aria-describedby="bibr51-19322968251362848">51</a>
</sup></p>
<p>When reporting reference intervals, it is essential to incorporate both pre-analytical and analytical variables. These include the sample type (plasma or serum), sample handling conditions, the analytical method used, whether fasting or stimulated C-peptide measurements were taken, and the source of the reference values if derived from existing literature.<sup>
<a href="#bibr52-19322968251362848" class="usa-link" aria-describedby="bibr52-19322968251362848">52</a>
</sup> In addition, factors such as body mass index (BMI), age, or kidney function can affect C-peptide values (<a href="https://cpeptide.org/assets/cpeptide2016.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cpeptide.org/assets/cpeptide2016.pdf</a>). Another critical aspect, often not thoroughly described during reporting or establishing reference ranges, is the selection criteria for the reference population. The definition of a “representative” healthy population can vary. Therefore, it is crucial to rigorously describe the process for establishing reference intervals, as this will aid in drafting guidelines on C-peptide and its broader applications.</p></section><section id="section12-19322968251362848"><h2 class="pmc_sec_title">C-Peptide Assay Discrepancies</h2>
<p>In 2001, an ADA workshop recommended global standardization of C-peptide assays.<sup>
<a href="#bibr19-19322968251362848" class="usa-link" aria-describedby="bibr19-19322968251362848">19</a>
</sup> Later, the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) supported this initiative, which continues to be coordinated by the University of Missouri.<sup>
<a href="#bibr18-19322968251362848" class="usa-link" aria-describedby="bibr18-19322968251362848">18</a>
</sup> This initiative was motivated by discrepancies observed in C-peptide measurements across different laboratories participating in clinical trials. The committee’s first study involved inter-assay and inter-laboratory comparisons across 15 laboratories in seven countries.<sup>
<a href="#bibr53-19322968251362848" class="usa-link" aria-describedby="bibr53-19322968251362848">53</a>
</sup> Ten methods, including radioimmunoassays and immunoassays, were compared using 14 heparin plasma samples. At least six methods were calibrated by the manufacturers using the WHO material 84/510. Two recalibration strategies were explored: one based on WHO material and another on four serum-based calibrators. The WHO material was serially diluted by each laboratory to prepare calibrators. In contrast, serum-based calibrators were assigned values using the same immunoassay, and these values were subsequently used for recalibration. The application of serum-based calibrators significantly improved inter-assay and inter-laboratory agreement, whereas calibration using WHO-based calibrators did not reduce discrepancies. Before recalibration, the standard deviations (SD) for inter-laboratory and inter-method variations ranged from 0.090 to 0.225 (95% confidence interval [CI]). After recalibration with serum samples, the range narrowed to 0.0 to 0.061 (95% CI) and no longer overlapped with the original range. This study was the first to demonstrate the importance of matrix-appropriate calibrators for the proper harmonization of C-peptide assays.</p>
<p>When the Liquid Chromatography-Mass Spectrometry (LC-MS) method for C-peptide became available to the standardization committee, another comparative study was conducted to examine how LC-MS could reduce discrepancies.<sup>
<a href="#bibr9-19322968251362848" class="usa-link" aria-describedby="bibr9-19322968251362848">9</a>
</sup> This study involved 15 laboratories across five countries and assessed nine different C-peptide assays. Eight serum samples were selected as calibrators, with values assigned by the LC-MS method. An additional 32 serum samples were then analyzed by each assay, both before and after recalibration using the eight calibrators. Prior to recalibration, statistically significant differences between laboratories were observed, with least-squares means ranging from 1.55 to 1.95, and all methods consistently overestimated C-peptide values compared to LC-MS. After recalibration, these differences were no longer statistically significant, and the range narrowed to 0.93 to 1.02. These results indicated that mass spectrometry-assigned values for serum samples significantly reduced discrepancies among methods. The reference method was later established at the University of Missouri, registered in the Joint Committee for Traceability in Laboratory Medicine (JCTLM), and calibrated against the National Metrology Institute of Japan (NMIJ) certified reference material (CRM) C-peptide material to establish a metrological traceability chain.<sup>
<a href="#bibr9-19322968251362848" class="usa-link" aria-describedby="bibr9-19322968251362848">9</a>
</sup> A more recent study from the group examined the effect of recalibration using the LC-MS reference method on 13 of the most frequently used C-peptide assays.<sup>
<a href="#bibr54-19322968251362848" class="usa-link" aria-describedby="bibr54-19322968251362848">54</a>
</sup> In this study, all measurements and recalibration procedures were conducted by the manufacturers themselves, following their standard protocols. The study was designed by initially sending a set of 20 serum samples to each manufacturer. Subsequently, another set of 20 serum samples was sent, accompanied by LC-MS-assigned values for the first set. Each manufacturer was instructed to recalibrate their assays based on the first set and provide both non-recalibrated and recalibrated values for the second set to assess the effect of standardization. Before recalibration, an overestimation compared to the reference method was evident across all assays, indicating a consistent systematic bias in all methods. Despite most of the assays (11 out of 13) being originally calibrated against the same 84/510 WHO C-peptide CRM, discrepancies among the assays were evident. After recalibration, 6 of 13 assays achieved full equivalence with the reference method assessed by the Passing-Bablok analysis. The remaining seven methods demonstrated partial agreement, either in terms of slope or intercept. Recalibration using the reference method reduced the systematic bias of each method relative to the reference method and decreased the disagreement among individual sample results across commercial methods. Another finding is that the situation does not seem to have changed regarding discrepancies in current assay results when compared to data from an older study.<sup>
<a href="#bibr55-19322968251362848" class="usa-link" aria-describedby="bibr55-19322968251362848">55</a>
</sup> This is somewhat disappointing, as we had expected some technological progress over more than a decade. Overall, the situation can be explained by the continued application of non-commutable C-peptide reference material by manufacturers.</p>
<p>Several other groups have independently examined C-peptide discrepancies. A survey conducted by sending five pooled serum samples to 94 clinical laboratories in China demonstrated significant discrepancies among C-peptide methods.<sup>
<a href="#bibr56-19322968251362848" class="usa-link" aria-describedby="bibr56-19322968251362848">56</a>
</sup> Laboratories in the study operated different measurement systems, represented by various manufacturer platforms and platform series. For example, the Roche Cobas system was represented by the e601, e602, e801, and E411 series. While the coefficient of variation (CV) within individual measurement systems was below 7%, the CV for inter-laboratory and inter-measurement system comparisons was 16.4% and 24.5%, respectively. After recalibration of three samples using two samples with the highest and lowest C-peptide values (calculated as the mean across all laboratories), the inter-measurement CV decreased from 31.6%, 22.1%, and 20.2% to 10.4%, 2.1%, and 4.6%, respectively. This study highlights that, in the absence of a reference method, harmonizing assays using pooled samples can reduce discrepancies. However, the accuracy of the results may still be questionable, as calibrators were assigned based on mean immunoassay values.</p>
<p>A recent study compared five commonly used platforms for C-peptide quantification in Germany.<sup>
<a href="#bibr47-19322968251362848" class="usa-link" aria-describedby="bibr47-19322968251362848">47</a>
</sup> Although all C-peptide assays were traceable to the same WHO 84/510 standard, the obtained C-peptide values varied significantly, with the largest difference reaching 36% between the two assay systems. Notably, a discrepancy was observed even between platforms from the same manufacturer; the Siemens Immulite 2000 XP and Siemens ADVIA Centaur XPT differed by 24.4%.</p>
<p>The effect of an error of 30% in C-peptide determination is illustrated by the following considerations: a difference of 30% between different assays would lead to a range of 140 to 260 pmol/L for the suggested cut-off of 200 pmol/L and 420 to 780 pmol/L for the suggested cut-off of 600 pmol/L, respectively. Thus, a patient with a true C-peptide of 200 pmol/L who obtains a C-peptide result of 160 pmol/L, this result will be interpreted as low, while a result of 240 pmol/L measured in another laboratory will be interpreted as not decreased, ie, “normal.” Thus, based on these C-peptide values, a diabetologist would start an insulin treatment when the patient has obtained a result of 160 pmol/L, while the same patient would not receive an insulin treatment when a C-peptide value of 240 pmol/L was determined. The corresponding considerations are also valid for the upper C-peptide cut-off.</p>
<p>All studies have been revealing a persistent issue of discrepancies among C-peptide assays over the last two decades. It seems evident that the situation will not improve on its own. Meanwhile, numerous clinical trials on type 1 diabetes, where C-peptide is used to monitor disease progression or treatment response, are ongoing.</p>
<p>Standardization can be achieved by incorporating a proper calibration scheme into manufacturers’ assay workflows. One way to accomplish this is by using calibrators based on serum samples, known as secondary reference materials, with values assigned by a reference method. This reference scheme is essential to ensuring assay comparability and achieving accurate C-peptide values.</p></section><section id="section13-19322968251362848"><h2 class="pmc_sec_title">Current Status of C-Peptide Standardization</h2>
<p>There is sometimes a misconception that standardization is achieved once comparison studies are performed and the reference method is registered with the JCTLM. However, published studies highlighting discrepancies and the development of a reference method represent only the initial stage of the standardization process. The ultimate goal is the global recalibration of assays by each manufacturer. After this recalibration is implemented, clinical laboratories conducting these tests are advised to regularly participate in accuracy-based external quality surveys. For C-peptide testing, this should involve serum samples assigned by LC-MS reference methods. This practice helps monitor assay changes that may occur between different method generations or even between lots. Ideally, a certification system—such as the National Glycohemoglobin Standardization Program (NGSP) for HbA<sub>1c</sub> or the CDC program for lipids—could be introduced, enabling manufacturers to demonstrate alignment with the reference system to their customers. This would enhance transparency and ensure consistent assay performance.</p>
<p>From our experience, the most challenging part of the program is finding a laboratory that can support a long-term reference method and collaborate on method comparisons and value assignments. This difficulty is likely due to the limited funding available for such activities, as they are not well supported by traditional funding sources, which tend to prioritize more exploratory and high-profile research. Even when a reference method is registered in the JCTLM, it does not necessarily mean that the method is still active. Often, once method development studies are completed and published, the method is not maintained or updated. This is especially true for LC-MS methods, which are highly sensitive to changes and may face challenges in long-term support. As a result, these types of programs are typically coordinated by large institutions with substantial federal funding. A notable example is the CDC, which supports several programs focused on lipids, hormones, and apolipoproteins.<sup><a href="#bibr57-19322968251362848" class="usa-link" aria-describedby="bibr57-19322968251362848">57</a>,<a href="#bibr58-19322968251362848" class="usa-link" aria-describedby="bibr58-19322968251362848">58</a></sup> Therefore, academic labs are an unusual setting for this type of activity. The University of Missouri Diagnostic Diabetes Laboratory is one of the few exceptions. Implementing the C-peptide program was possible due to the lab’s extensive experience with HbA<sub>1c</sub> standardization and continuous support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/NIH.</p>
<p>Currently, everything is in place for C-peptide: a reference method, an established primary reference material, a secondary calibrator set, and a complete traceability chain. In addition, we have industry collaboration for method comparison and regular feedback regarding their methods. However, a critical piece is still missing—companies remain reluctant to recalibrate their methods, creating a dead end for these efforts. Two key factors could drive manufacturers to take action: regulatory requirements and business initiatives, both influenced by demands from health care providers.</p>
<p>The criteria for assay approval depend on the local regulatory body, whether it is the FDA, European Notified Bodies, or other country-specific agencies. In Europe, regulators require traceability due to the 1998 European Union (EU) Directive which states that “The traceability of values assigned to calibrators and/or control materials must be assured through available reference measurement procedures and/or available reference materials of a higher order.” However, a significant challenge remains: despite traceability having already been established—with all C-peptide assays traceable to WHO reference materials (WHO 84/510 and WHO 13/146)—discrepancies persist. These reference materials do not mimic patient samples, and each immunoassay measures them differently compared to the serum matrix, resulting in non-commutability.</p>
<p>Manufacturers are often reluctant to modify or recalibrate their assays, due to the associated costs. In addition, if the changes are significant, they may be required to undergo additional regulatory approval. Thus, standardization efforts remain stalled in limbo. Clinical trials and C-peptide measurements present a classic chicken-and-egg dilemma: without accurate measurements, drawing definitive conclusions from clinical trials and meta-analyses—which are essential for establishing guidelines—becomes unattainable. Conversely, without established guidelines, there is little regulatory pressure to improve measurement accuracy and consistency. Another complication is that the translation of clinical trial findings into guidelines is a lengthy and costly process, further delaying progress.</p>
<p>Another concern is the widely used diagnostic threshold for C-peptide levels in type 1 diabetes, set at 0.2 nmol/L. This threshold was established based on data from the DCCT. However, its relevance today is uncertain. The original DCCT measurements were conducted using a radioimmunoassay with the M-1230 anti-C-peptide antibody from Nova Industri.<sup>
<a href="#bibr40-19322968251362848" class="usa-link" aria-describedby="bibr40-19322968251362848">40</a>
</sup> Since this method is no longer available, it is unclear how these historical measurements compare to results obtained using modern analytical techniques.</p>
<p>Aside from the discussed analytical variations, a main problem arises when cut-off values are derived from clinical trials and advocated for clinical care. In clinical trials well-defined cohorts are studied. Not unexpected, the different clinical trials reported different cut-off values. For example, insulin resistance cut-off values vary from 1.55 (in a study from Thailand; n = 738; age: ≥35 years, normal BMI, and fasting glucose) to ≥3.8 (in a study from France, n = 1153, age: 35-64 years, population-based sample).<sup>
<a href="#bibr59-19322968251362848" class="usa-link" aria-describedby="bibr59-19322968251362848">59</a>
</sup> Since cut-off values may depend on gender, age, ethnicity, metabolic stage, and so on, the reported cut-off values should be used with cause in the daily clinical practice.</p></section><section id="section14-19322968251362848"><h2 class="pmc_sec_title">Conclusion: Need for C-Peptide Standardization</h2>
<p>C-peptide is an emerging biomarker for assessing β-cell function and is increasingly used in the classification, diagnosis, and management of diabetes. However, the slow progress in the standardization of its measurement limits its clinical utility. Assay discrepancies hinder the application of diagnostic cut-offs and compromise therapeutic decisions and clinical trial outcomes. Although reference methods and materials, as well as a traceability scheme, are now available, widespread implementation remains stalled. Action is needed, as standardized C-peptide measurement is essential for advancing both diabetes care and research.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn3"><p>DM, diabetes mellitus; ADA, American diabetes association; EASD, European association for the study of diabetes; WHO, world health organization; MODY, maturity-onset diabetes of the young; LADA, latent autoimmune diabetes in adults; CGM, continuous glucose monitor; GST, glucagon stimulation test; MMTT, mixed-meal tolerance test; oGTT, oral glucose tolerance test; CGR, C-peptide/glucose ratio; AUC, area under the curve; EDIC, epidemiology of diabetes interventions and complications; SDRNT1BIO, scottish diabetes research network type 1 bioresource; CITR, collaborative islet transplant Registry; FDA, food and drug administration; NIH, national institutes of health; CDC, centers for disease control and prevention; LC-MS, liquid chromatography-mass spectrometry; NMIJ, national metrology institute of Japan; CRM, certified reference material; NGSP, national glycohemoglobin standardization program; NIDDK, national institute of diabetes and digestive and kidney diseases; JCTLM, joint committee for traceability in laboratory medicine.</p></div>
<div class="fn p" id="fn4"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></div>
<div class="fn p" id="fn5"><p><strong>Funding:</strong> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></div>
<div class="fn p" id="fn6">
<p><strong>ORCID iDs:</strong> Erwin Schleicher <img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6e/12335430/03e617e2a807/10.1177_19322968251362848-img1.jpg" loading="lazy" alt="Inline graphic">
<a href="https://orcid.org/0000-0003-3565-3733" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-3565-3733</a></p>
<p>Lutz Heinemann <img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c6e/12335430/03e617e2a807/10.1177_19322968251362848-img1.jpg" loading="lazy" alt="Inline graphic">
<a href="https://orcid.org/0000-0003-2493-1304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-2493-1304</a></p>
</div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bibr1-19322968251362848">
<span class="label">1.</span><cite>2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(suppl 1):S20-S42. doi: 10.2337/dc24-S002</cite> [<a href="https://doi.org/10.2337/dc24-S002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10725812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38078589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=2.%20Diagnosis%20and%20classification%20of%20diabetes:%20standards%20of%20care%20in%20diabetes-2024&amp;volume=47&amp;issue=suppl%201&amp;publication_year=2024&amp;pmid=38078589&amp;doi=10.2337/dc24-S002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr2-19322968251362848">
<span class="label">2.</span><cite>
Pleus S, Tytko A, Landgraf R, et al. Definition, classification, diagnosis and differential diagnosis of diabetes mellitus: update 2023. Exp Clin Endocrinol Diabetes. 2024;132(3):112-124. doi: 10.1055/a-2166-6643
</cite> [<a href="https://doi.org/10.1055/a-2166-6643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38378016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Clin%20Endocrinol%20Diabetes&amp;title=Definition,%20classification,%20diagnosis%20and%20differential%20diagnosis%20of%20diabetes%20mellitus:%20update%202023&amp;author=S%20Pleus&amp;author=A%20Tytko&amp;author=R%20Landgraf&amp;volume=132&amp;issue=3&amp;publication_year=2024&amp;pages=112-124&amp;pmid=38378016&amp;doi=10.1055/a-2166-6643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr3-19322968251362848">
<span class="label">3.</span><cite>
Thomas NJ, Lynam AL, Hill AV, et al. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia. 2019;62(7):1167-1172. doi: 10.1007/s00125-019-4863-8
</cite> [<a href="https://doi.org/10.1007/s00125-019-4863-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6559997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30969375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Type%201%20diabetes%20defined%20by%20severe%20insulin%20deficiency%20occurs%20after%2030%20years%20of%20age%20and%20is%20commonly%20treated%20as%20type%202%20diabetes&amp;author=NJ%20Thomas&amp;author=AL%20Lynam&amp;author=AV%20Hill&amp;volume=62&amp;issue=7&amp;publication_year=2019&amp;pages=1167-1172&amp;pmid=30969375&amp;doi=10.1007/s00125-019-4863-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr4-19322968251362848">
<span class="label">4.</span><cite>
Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. doi: 10.2337/dci21-0043
</cite> [<a href="https://doi.org/10.2337/dci21-0043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34593612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=The%20management%20of%20type%201%20diabetes%20in%20adults.%20a%20consensus%20report%20by%20the%20American%20Diabetes%20Association%20(ADA)%20and%20the%20European%20Association%20for%20the%20Study%20of%20Diabetes%20(EASD)&amp;author=RIG%20Holt&amp;author=JH%20DeVries&amp;author=A%20Hess-Fischl&amp;volume=44&amp;issue=11&amp;publication_year=2021&amp;pages=2589-2625&amp;pmid=34593612&amp;doi=10.2337/dci21-0043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr5-19322968251362848">
<span class="label">5.</span><cite>
Committee ADAPP. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care. 2024;48(suppl 1):S27-S49. doi: 10.2337/dc25-S002</cite> [<a href="https://doi.org/10.2337/dc25-S002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11635041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39651986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=2.%20Diagnosis%20and%20classification%20of%20diabetes:%20standards%20of%20care%20in%20diabetes%E2%80%942025&amp;volume=48&amp;issue=suppl%201&amp;publication_year=2024&amp;pmid=39651986&amp;doi=10.2337/dc25-S002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr6-19322968251362848">
<span class="label">6.</span><cite>
Ke C, Narayan KMV, Chan JCN, Jha P, Shah BR. Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nat Rev Endocrinol. 2022;18(7):413-432. doi: 10.1038/s41574-022-00669-4
</cite> [<a href="https://doi.org/10.1038/s41574-022-00669-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9067000/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35508700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Endocrinol&amp;title=Pathophysiology,%20phenotypes%20and%20management%20of%20type%202%20diabetes%20mellitus%20in%20Indian%20and%20Chinese%20populations&amp;author=C%20Ke&amp;author=KMV%20Narayan&amp;author=JCN%20Chan&amp;author=P%20Jha&amp;author=BR%20Shah&amp;volume=18&amp;issue=7&amp;publication_year=2022&amp;pages=413-432&amp;pmid=35508700&amp;doi=10.1038/s41574-022-00669-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr7-19322968251362848">
<span class="label">7.</span><cite>
Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2
</cite> [<a href="https://doi.org/10.1016/S2213-8587(18)30051-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29503172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol&amp;title=Novel%20subgroups%20of%20adult-onset%20diabetes%20and%20their%20association%20with%20outcomes:%20a%20data-driven%20cluster%20analysis%20of%20six%20variables&amp;author=E%20Ahlqvist&amp;author=P%20Storm&amp;author=A%20K%C3%A4r%C3%A4j%C3%A4m%C3%A4ki&amp;volume=6&amp;issue=5&amp;publication_year=2018&amp;pages=361-369&amp;pmid=29503172&amp;doi=10.1016/S2213-8587(18)30051-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr8-19322968251362848">
<span class="label">8.</span><cite>
Fritsche A, Heni M, Peter A, et al. Considering insulin secretory capacity as measured by a fasting C-peptide/glucose ratio in selecting glucose-lowering medications. Exp Clin Endocrinol Diabetes. 2022;130(3):200-204. doi: 10.1055/a-1242-9809
</cite> [<a href="https://doi.org/10.1055/a-1242-9809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8926455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32947641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Clin%20Endocrinol%20Diabetes&amp;title=Considering%20insulin%20secretory%20capacity%20as%20measured%20by%20a%20fasting%20C-peptide/glucose%20ratio%20in%20selecting%20glucose-lowering%20medications&amp;author=A%20Fritsche&amp;author=M%20Heni&amp;author=A%20Peter&amp;volume=130&amp;issue=3&amp;publication_year=2022&amp;pages=200-204&amp;pmid=32947641&amp;doi=10.1055/a-1242-9809&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr9-19322968251362848">
<span class="label">9.</span><cite>
Little RR, Wielgosz RI, Josephs R, et al. Implementing a reference measurement system for C-peptide: successes and lessons learned. Clin Chem. 2017;63(9):1447-1456. doi: 10.1373/clinchem.2016.269274
</cite> [<a href="https://doi.org/10.1373/clinchem.2016.269274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5575958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28646033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Implementing%20a%20reference%20measurement%20system%20for%20C-peptide:%20successes%20and%20lessons%20learned&amp;author=RR%20Little&amp;author=RI%20Wielgosz&amp;author=R%20Josephs&amp;volume=63&amp;issue=9&amp;publication_year=2017&amp;pages=1447-1456&amp;pmid=28646033&amp;doi=10.1373/clinchem.2016.269274&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr10-19322968251362848">
<span class="label">10.</span><cite>
Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017;8(3):475-487. doi: 10.1007/s13300-017-0265-4
</cite> [<a href="https://doi.org/10.1007/s13300-017-0265-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5446389/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28484968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Ther&amp;title=A%20practical%20review%20of%20C-peptide%20testing%20in%20diabetes&amp;author=E%20Leighton&amp;author=CA%20Sainsbury&amp;author=GC%20Jones&amp;volume=8&amp;issue=3&amp;publication_year=2017&amp;pages=475-487&amp;pmid=28484968&amp;doi=10.1007/s13300-017-0265-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr11-19322968251362848">
<span class="label">11.</span><cite>
Bonnefond A, Unnikrishnan R, Doria A, et al. Monogenic diabetes. Nat Rev Dis Primers. 2023;9(1):12. doi: 10.1038/s41572-023-00421-w
</cite> [<a href="https://doi.org/10.1038/s41572-023-00421-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36894549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Dis%20Primers&amp;title=Monogenic%20diabetes&amp;author=A%20Bonnefond&amp;author=R%20Unnikrishnan&amp;author=A%20Doria&amp;volume=9&amp;issue=1&amp;publication_year=2023&amp;pages=12&amp;pmid=36894549&amp;doi=10.1038/s41572-023-00421-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr12-19322968251362848">
<span class="label">12.</span><cite>
Leslie RD, Evans-Molina C, Freund-Brown J, et al. Adult-onset type 1 diabetes: current understanding and challenges. Diabetes Care. 2021;44(11):2449-2456. doi: 10.2337/dc21-0770
</cite> [<a href="https://doi.org/10.2337/dc21-0770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8546280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34670785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Adult-onset%20type%201%20diabetes:%20current%20understanding%20and%20challenges&amp;author=RD%20Leslie&amp;author=C%20Evans-Molina&amp;author=J%20Freund-Brown&amp;volume=44&amp;issue=11&amp;publication_year=2021&amp;pages=2449-2456&amp;pmid=34670785&amp;doi=10.2337/dc21-0770&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr13-19322968251362848">
<span class="label">13.</span><cite>
Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR, 3rd, Aguilar RB. The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016;39(2):179-186. doi: 10.2337/dc15-1585
</cite> [<a href="https://doi.org/10.2337/dc15-1585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5317235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26798148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=The%20time%20is%20right%20for%20a%20new%20classification%20system%20for%20diabetes:%20rationale%20and%20implications%20of%20the%20%CE%B2-cell-centric%20classification%20schema&amp;author=SS%20Schwartz&amp;author=S%20Epstein&amp;author=BE%20Corkey&amp;author=SF%20Grant&amp;author=JR%20Gavin&amp;volume=39&amp;issue=2&amp;publication_year=2016&amp;pages=179-186&amp;pmid=26798148&amp;doi=10.2337/dc15-1585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr14-19322968251362848">
<span class="label">14.</span><cite>
Couri CEB, Malmegrim KCR, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Front Immunol. 2018;9:1086. doi: 10.3389/fimmu.2018.01086
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5968392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29868031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=New%20horizons%20in%20the%20treatment%20of%20type%201%20diabetes:%20more%20intense%20immunosuppression%20and%20beta%20cell%20replacement&amp;author=CEB%20Couri&amp;author=KCR%20Malmegrim&amp;author=MC%20Oliveira&amp;volume=9&amp;publication_year=2018&amp;pages=1086&amp;pmid=29868031&amp;doi=10.3389/fimmu.2018.01086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr15-19322968251362848">
<span class="label">15.</span><cite>
Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, Raymond R, Ramos EL. Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves beta-cell function. Diabetes Care. 2023;46(10):1848-1856. doi: 10.2337/dc23-0675
</cite> [<a href="https://doi.org/10.2337/dc23-0675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10545553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37607392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Teplizumab:%20a%20disease-modifying%20therapy%20for%20type%201%20diabetes%20that%20preserves%20beta-cell%20function&amp;author=KC%20Herold&amp;author=SE%20Gitelman&amp;author=PA%20Gottlieb&amp;author=LA%20Knecht&amp;author=R%20Raymond&amp;volume=46&amp;issue=10&amp;publication_year=2023&amp;pages=1848-1856&amp;pmid=37607392&amp;doi=10.2337/dc23-0675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr16-19322968251362848">
<span class="label">16.</span><cite>
Dario T, Riccardo G, Silvia P, et al. The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study. Acta Diabetol. 2021;58(4):411-417. doi: 10.1007/s00592-020-01634-1
</cite> [<a href="https://doi.org/10.1007/s00592-020-01634-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33185778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Diabetol&amp;title=The%20utility%20of%20assessing%20C-peptide%20in%20patients%20with%20insulin-treated%20type%202%20diabetes:%20a%20cross-sectional%20study&amp;author=T%20Dario&amp;author=G%20Riccardo&amp;author=P%20Silvia&amp;volume=58&amp;issue=4&amp;publication_year=2021&amp;pages=411-417&amp;pmid=33185778&amp;doi=10.1007/s00592-020-01634-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr17-19322968251362848">
<span class="label">17.</span><cite>
Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care. 2008;31(10):1966-1971. doi: 10.2337/dc07-2451
</cite> [<a href="https://doi.org/10.2337/dc07-2451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2551636/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18628574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Mixed-meal%20tolerance%20test%20versus%20glucagon%20stimulation%20test%20for%20the%20assessment%20of%20beta-cell%20function%20in%20therapeutic%20trials%20in%20type%201%20diabetes&amp;author=CJ%20Greenbaum&amp;author=T%20Mandrup-Poulsen&amp;author=PF%20McGee&amp;volume=31&amp;issue=10&amp;publication_year=2008&amp;pages=1966-1971&amp;pmid=18628574&amp;doi=10.2337/dc07-2451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr18-19322968251362848">
<span class="label">18.</span><cite>
Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes. 2004;53(1):250-264. doi: 10.2337/diabetes.53.1.250
</cite> [<a href="https://doi.org/10.2337/diabetes.53.1.250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14693724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=C-peptide%20is%20the%20appropriate%20outcome%20measure%20for%20type%201%20diabetes%20clinical%20trials%20to%20preserve%20beta-cell%20function:%20report%20of%20an%20ADA%20workshop,%2021-22%20October%202001&amp;author=JP%20Palmer&amp;author=GA%20Fleming&amp;author=CJ%20Greenbaum&amp;volume=53&amp;issue=1&amp;publication_year=2004&amp;pages=250-264&amp;pmid=14693724&amp;doi=10.2337/diabetes.53.1.250&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr19-19322968251362848">
<span class="label">19.</span><cite>
Sokooti S, Kieneker LM, Borst MH, et al. Plasma C-peptide and risk of developing type 2 diabetes in the general population. J Clin Med. 2020;9(9):3001. doi: 10.3390/jcm9093001
</cite> [<a href="https://doi.org/10.3390/jcm9093001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7564789/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32957570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=Plasma%20C-peptide%20and%20risk%20of%20developing%20type%202%20diabetes%20in%20the%20general%20population&amp;author=S%20Sokooti&amp;author=LM%20Kieneker&amp;author=MH%20Borst&amp;volume=9&amp;issue=9&amp;publication_year=2020&amp;pages=3001&amp;pmid=32957570&amp;doi=10.3390/jcm9093001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr20-19322968251362848">
<span class="label">20.</span><cite>
Sosenko JM, Palmer JP, Greenbaum CJ, et al. Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-Type 1. Diabetes Care. 2006;29(3):643-649. doi: 10.2337/diacare.29.03.06.dc05-1006
</cite> [<a href="https://doi.org/10.2337/diacare.29.03.06.dc05-1006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16505520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Patterns%20of%20metabolic%20progression%20to%20type%201%20diabetes%20in%20the%20diabetes%20prevention%20trial-Type%201&amp;author=JM%20Sosenko&amp;author=JP%20Palmer&amp;author=CJ%20Greenbaum&amp;volume=29&amp;issue=3&amp;publication_year=2006&amp;pages=643-649&amp;pmid=16505520&amp;doi=10.2337/diacare.29.03.06.dc05-1006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr21-19322968251362848">
<span class="label">21.</span><cite>
Yazidi M, Mahjoubi S, Oueslati I, Chaker F, Chihaoui M. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up. Arch Endocrinol Metab. 2022;66(2):222-228. doi: 10.20945/2359-3997000000456
</cite> [<a href="https://doi.org/10.20945/2359-3997000000456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9832884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35315990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Endocrinol%20Metab&amp;title=The%20remission%20phase%20in%20adolescents%20and%20young%20adults%20with%20newly%20diagnosed%20type%201%20diabetes%20mellitus:%20prevalence,%20predicting%20factors%20and%20glycemic%20control%20during%20follow-up&amp;author=M%20Yazidi&amp;author=S%20Mahjoubi&amp;author=I%20Oueslati&amp;author=F%20Chaker&amp;author=M%20Chihaoui&amp;volume=66&amp;issue=2&amp;publication_year=2022&amp;pages=222-228&amp;pmid=35315990&amp;doi=10.20945/2359-3997000000456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr22-19322968251362848">
<span class="label">22.</span><cite>
Schatz D, Cuthbertson D, Atkinson M, et al. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus—a new surrogate measure of non-progression?
Pediatr Diabetes. 2004;5(2):72-79. doi: 10.1111/j.1399-543X.2004.00047.x
</cite> [<a href="https://doi.org/10.1111/j.1399-543X.2004.00047.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15189492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Diabetes&amp;title=Preservation%20of%20C-peptide%20secretion%20in%20subjects%20at%20high%20risk%20of%20developing%20type%201%20diabetes%20mellitus%E2%80%94a%20new%20surrogate%20measure%20of%20non-progression?&amp;author=D%20Schatz&amp;author=D%20Cuthbertson&amp;author=M%20Atkinson&amp;volume=5&amp;issue=2&amp;publication_year=2004&amp;pages=72-79&amp;pmid=15189492&amp;doi=10.1111/j.1399-543X.2004.00047.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr23-19322968251362848">
<span class="label">23.</span><cite>
Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013;30(7):803-817. doi: 10.1111/dme.12159
</cite> [<a href="https://doi.org/10.1111/dme.12159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3748788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23413806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabet%20Med&amp;title=The%20clinical%20utility%20of%20C-peptide%20measurement%20in%20the%20care%20of%20patients%20with%20diabetes&amp;author=AG%20Jones&amp;author=AT%20Hattersley&amp;volume=30&amp;issue=7&amp;publication_year=2013&amp;pages=803-817&amp;pmid=23413806&amp;doi=10.1111/dme.12159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr24-19322968251362848">
<span class="label">24.</span><cite>
Butler AE, Misselbrook D. Distinguishing between type 1 and type 2 diabetes. BMJ. 2020;370:m2998. doi: 10.1136/bmj.m2998</cite> [<a href="https://doi.org/10.1136/bmj.m2998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32784223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Distinguishing%20between%20type%201%20and%20type%202%20diabetes&amp;author=AE%20Butler&amp;author=D%20Misselbrook&amp;volume=370&amp;publication_year=2020&amp;pmid=32784223&amp;doi=10.1136/bmj.m2998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr25-19322968251362848">
<span class="label">25.</span><cite>
Maddaloni E, Bolli GB, Frier BM, et al. C-peptide determination in the diagnosis of type of diabetes and its management: a clinical perspective. Diabetes Obes Metab. 2022;24(10):1912-1926. doi: 10.1111/dom.14785
</cite> [<a href="https://doi.org/10.1111/dom.14785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9543865/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35676794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Obes%20Metab&amp;title=C-peptide%20determination%20in%20the%20diagnosis%20of%20type%20of%20diabetes%20and%20its%20management:%20a%20clinical%20perspective&amp;author=E%20Maddaloni&amp;author=GB%20Bolli&amp;author=BM%20Frier&amp;volume=24&amp;issue=10&amp;publication_year=2022&amp;pages=1912-1926&amp;pmid=35676794&amp;doi=10.1111/dom.14785&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr26-19322968251362848">
<span class="label">26.</span><cite>
Berger B, Stenström G, Sundkvist G. Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest. 2000;60(8):687-693. doi: 10.1080/00365510050216411
</cite> [<a href="https://doi.org/10.1080/00365510050216411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11218151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scand%20J%20Clin%20Lab%20Invest&amp;title=Random%20C-peptide%20in%20the%20classification%20of%20diabetes&amp;author=B%20Berger&amp;author=G%20Stenstr%C3%B6m&amp;author=G%20Sundkvist&amp;volume=60&amp;issue=8&amp;publication_year=2000&amp;pages=687-693&amp;pmid=11218151&amp;doi=10.1080/00365510050216411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr27-19322968251362848">
<span class="label">27.</span><cite>
Alemán-Contreras R, Gómez-Díaz RA, Noyola-García ME, Mondragón-González R, Wacher N, Ferreira-Hermosillo A. Utility of fasting C-peptide for the diagnostic differentiation of patients with type 1, type 2 diabetes, MODY, and LADA. Life. 2024;14:550-558.
</cite> [<a href="https://doi.org/10.3390/life14050550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11122504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38792571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Life&amp;title=Utility%20of%20fasting%20C-peptide%20for%20the%20diagnostic%20differentiation%20of%20patients%20with%20type%201,%20type%202%20diabetes,%20MODY,%20and%20LADA&amp;author=R%20Alem%C3%A1n-Contreras&amp;author=RA%20G%C3%B3mez-D%C3%ADaz&amp;author=ME%20Noyola-Garc%C3%ADa&amp;author=R%20Mondrag%C3%B3n-Gonz%C3%A1lez&amp;author=N%20Wacher&amp;volume=14&amp;publication_year=2024&amp;pages=550-558&amp;pmid=38792571&amp;doi=10.3390/life14050550&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr28-19322968251362848">
<span class="label">28.</span><cite>
Wagner R, Heni M, Tabák AG, et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med. 2021;27(1):49-57. doi: 10.1038/s41591-020-1116-9
</cite> [<a href="https://doi.org/10.1038/s41591-020-1116-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33398163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Pathophysiology-based%20subphenotyping%20of%20individuals%20at%20elevated%20risk%20for%20type%202%20diabetes&amp;author=R%20Wagner&amp;author=M%20Heni&amp;author=AG%20Tab%C3%A1k&amp;volume=27&amp;issue=1&amp;publication_year=2021&amp;pages=49-57&amp;pmid=33398163&amp;doi=10.1038/s41591-020-1116-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr29-19322968251362848">
<span class="label">29.</span><cite>
Latres E, Greenbaum CJ, Oyaski ML, et al. Evidence for C-peptide as a validated surrogate to predict clinical benefits in trials of disease-modifying therapies for type 1 diabetes. Diabetes. 2024;73(6):823-833. doi: 10.2337/dbi23-0012
</cite> [<a href="https://doi.org/10.2337/dbi23-0012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38349844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Evidence%20for%20C-peptide%20as%20a%20validated%20surrogate%20to%20predict%20clinical%20benefits%20in%20trials%20of%20disease-modifying%20therapies%20for%20type%201%20diabetes&amp;author=E%20Latres&amp;author=CJ%20Greenbaum&amp;author=ML%20Oyaski&amp;volume=73&amp;issue=6&amp;publication_year=2024&amp;pages=823-833&amp;pmid=38349844&amp;doi=10.2337/dbi23-0012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr30-19322968251362848">
<span class="label">30.</span><cite>
Fritsche A. Insulin secretion capacity as a crucial feature to distinguish type 1 from type 2 diabetes and to indicate the need for insulin therapy: a critical discussion of the ADA/EASD consensus statement on the management of type 1 diabetes in adults. Exp Clin Endocrinol Diabetes. 2023;131(9):500-503. doi: 10.1055/a-2016-8392
</cite> [<a href="https://doi.org/10.1055/a-2016-8392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10581093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37308105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Clin%20Endocrinol%20Diabetes&amp;title=Insulin%20secretion%20capacity%20as%20a%20crucial%20feature%20to%20distinguish%20type%201%20from%20type%202%20diabetes%20and%20to%20indicate%20the%20need%20for%20insulin%20therapy:%20a%20critical%20discussion%20of%20the%20ADA/EASD%20consensus%20statement%20on%20the%20management%20of%20type%201%20diabetes%20in%20adults&amp;author=A%20Fritsche&amp;volume=131&amp;issue=9&amp;publication_year=2023&amp;pages=500-503&amp;pmid=37308105&amp;doi=10.1055/a-2016-8392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr31-19322968251362848">
<span class="label">31.</span><cite>
Christensen MB, Gæde P, Hommel E, Gotfredsen A, Nørgaard K. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes. Diabetes Metab. 2020;46(1):61-65. doi: 10.1016/j.diabet.2019.02.002
</cite> [<a href="https://doi.org/10.1016/j.diabet.2019.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30796973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Metab&amp;title=Glycaemic%20variability%20and%20hypoglycaemia%20are%20associated%20with%20C-peptide%20levels%20in%20insulin-treated%20type%202%20diabetes&amp;author=MB%20Christensen&amp;author=P%20G%C3%A6de&amp;author=E%20Hommel&amp;author=A%20Gotfredsen&amp;author=K%20N%C3%B8rgaard&amp;volume=46&amp;issue=1&amp;publication_year=2020&amp;pages=61-65&amp;pmid=30796973&amp;doi=10.1016/j.diabet.2019.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr32-19322968251362848">
<span class="label">32.</span><cite>
Buzzetti R, Tuomi T, Mauricio D, et al. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020;69(10):2037-2047. doi: 10.2337/dbi20-0017
</cite> [<a href="https://doi.org/10.2337/dbi20-0017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7809717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32847960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Management%20of%20latent%20autoimmune%20diabetes%20in%20adults:%20a%20consensus%20statement%20from%20an%20international%20expert%20panel&amp;author=R%20Buzzetti&amp;author=T%20Tuomi&amp;author=D%20Mauricio&amp;volume=69&amp;issue=10&amp;publication_year=2020&amp;pages=2037-2047&amp;pmid=32847960&amp;doi=10.2337/dbi20-0017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr33-19322968251362848">
<span class="label">33.</span><cite>
Rosenstock J, Nino A, Soffer J, et al. Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: a randomized trial. Diabetes Care. 2020;43(10):2509-2518. doi: 10.2337/dc19-2316
</cite> [<a href="https://doi.org/10.2337/dc19-2316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7510023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32694215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Impact%20of%20a%20weekly%20glucagon-like%20peptide%201%20receptor%20agonist,%20albiglutide,%20on%20glycemic%20control%20and%20on%20reducing%20prandial%20insulin%20use%20in%20type%202%20diabetes%20inadequately%20controlled%20on%20multiple%20insulin%20therapy:%20a%20randomized%20trial&amp;author=J%20Rosenstock&amp;author=A%20Nino&amp;author=J%20Soffer&amp;volume=43&amp;issue=10&amp;publication_year=2020&amp;pages=2509-2518&amp;pmid=32694215&amp;doi=10.2337/dc19-2316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr34-19322968251362848">
<span class="label">34.</span><cite>
Bolli GB, Porcellati F, Meier JJ. Switching from insulin bolus treatment to GLP-1 RAs added to continued basal insulin in people with type 2 diabetes on basal-bolus insulin. Diabetes Care. 2020;43(10):2333-2335. doi: 10.2337/dci20-0038
</cite> [<a href="https://doi.org/10.2337/dci20-0038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32958617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Switching%20from%20insulin%20bolus%20treatment%20to%20GLP-1%20RAs%20added%20to%20continued%20basal%20insulin%20in%20people%20with%20type%202%20diabetes%20on%20basal-bolus%20insulin&amp;author=GB%20Bolli&amp;author=F%20Porcellati&amp;author=JJ%20Meier&amp;volume=43&amp;issue=10&amp;publication_year=2020&amp;pages=2333-2335&amp;pmid=32958617&amp;doi=10.2337/dci20-0038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr35-19322968251362848">
<span class="label">35.</span><cite>
Cardellini M, Farcomeni A, Ballanti M, et al. C-peptide: a predictor of cardiovascular mortality in subjects with established atherosclerotic disease. Diab Vasc Dis Res. 2017;14(5):395-399. doi: 10.1177/1479164117710446
</cite> [<a href="https://doi.org/10.1177/1479164117710446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28565926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diab%20Vasc%20Dis%20Res&amp;title=C-peptide:%20a%20predictor%20of%20cardiovascular%20mortality%20in%20subjects%20with%20established%20atherosclerotic%20disease&amp;author=M%20Cardellini&amp;author=A%20Farcomeni&amp;author=M%20Ballanti&amp;volume=14&amp;issue=5&amp;publication_year=2017&amp;pages=395-399&amp;pmid=28565926&amp;doi=10.1177/1479164117710446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr36-19322968251362848">
<span class="label">36.</span><cite>
Sosenko JM, Palmer JP, Rafkin-Mervis L, et al. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care. 2008;31(11):2188-2192. doi: 10.2337/dc08-0935
</cite> [<a href="https://doi.org/10.2337/dc08-0935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2571043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18650369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Glucose%20and%20C-peptide%20changes%20in%20the%20perionset%20period%20of%20type%201%20diabetes%20in%20the%20diabetes%20prevention%20trial-type%201&amp;author=JM%20Sosenko&amp;author=JP%20Palmer&amp;author=L%20Rafkin-Mervis&amp;volume=31&amp;issue=11&amp;publication_year=2008&amp;pages=2188-2192&amp;pmid=18650369&amp;doi=10.2337/dc08-0935&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr37-19322968251362848">
<span class="label">37.</span><cite>
Bogun MM, Bundy BN, Goland RS, Greenbaum CJ. C-peptide levels in subjects followed longitudinally before and after type 1 diabetes diagnosis in TrialNet. Diabetes Care. 2020;43(8):1836-1842. doi: 10.2337/dc19-2288
</cite> [<a href="https://doi.org/10.2337/dc19-2288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7372058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32457058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=C-peptide%20levels%20in%20subjects%20followed%20longitudinally%20before%20and%20after%20type%201%20diabetes%20diagnosis%20in%20TrialNet&amp;author=MM%20Bogun&amp;author=BN%20Bundy&amp;author=RS%20Goland&amp;author=CJ%20Greenbaum&amp;volume=43&amp;issue=8&amp;publication_year=2020&amp;pages=1836-1842&amp;pmid=32457058&amp;doi=10.2337/dc19-2288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr38-19322968251362848">
<span class="label">38.</span><cite>
Besser RE, Shields BM, Casas R, Hattersley AT, Ludvigsson J. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care. 2013;36(2):195-201. doi: 10.2337/dc12-0836
</cite> [<a href="https://doi.org/10.2337/dc12-0836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3554273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23111058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Lessons%20from%20the%20mixed-meal%20tolerance%20test:%20use%20of%2090-minute%20and%20fasting%20C-peptide%20in%20pediatric%20diabetes&amp;author=RE%20Besser&amp;author=BM%20Shields&amp;author=R%20Casas&amp;author=AT%20Hattersley&amp;author=J%20Ludvigsson&amp;volume=36&amp;issue=2&amp;publication_year=2013&amp;pages=195-201&amp;pmid=23111058&amp;doi=10.2337/dc12-0836&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr39-19322968251362848">
<span class="label">39.</span><cite>
Ylescupidez A, Bahnson HT, O’Rourke C, Lord S, Speake C, Greenbaum CJ. A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes. Nature Commun. 2023;14(1):7214. doi: 10.1038/s41467-023-42581-z
</cite> [<a href="https://doi.org/10.1038/s41467-023-42581-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10632453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37940642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Commun&amp;title=A%20standardized%20metric%20to%20enhance%20clinical%20trial%20design%20and%20outcome%20interpretation%20in%20type%201%20diabetes&amp;author=A%20Ylescupidez&amp;author=HT%20Bahnson&amp;author=C%20O%E2%80%99Rourke&amp;author=S%20Lord&amp;author=C%20Speake&amp;volume=14&amp;issue=1&amp;publication_year=2023&amp;pages=7214&amp;pmid=37940642&amp;doi=10.1038/s41467-023-42581-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr40-19322968251362848">
<span class="label">40.</span><cite>
Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab. 1987;65(1):30-36. doi: 10.1210/jcem-65-1-30
</cite> [<a href="https://doi.org/10.1210/jcem-65-1-30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2884229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=The%20DCCT%20Research%20Group&amp;volume=65&amp;issue=1&amp;publication_year=1987&amp;pages=30-36&amp;pmid=2884229&amp;doi=10.1210/jcem-65-1-30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr41-19322968251362848">
<span class="label">41.</span><cite>
Taylor PN, Collins KS, Lam A, et al. C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis. Lancet Diabetes Endocrinol. 2023;11(12):915-925. doi: 10.1016/S2213-8587(23)00267-X
</cite> [<a href="https://doi.org/10.1016/S2213-8587(23)00267-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37931637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol&amp;title=C-peptide%20and%20metabolic%20outcomes%20in%20trials%20of%20disease%20modifying%20therapy%20in%20new-onset%20type%201%20diabetes:%20an%20individual%20participant%20meta-analysis&amp;author=PN%20Taylor&amp;author=KS%20Collins&amp;author=A%20Lam&amp;volume=11&amp;issue=12&amp;publication_year=2023&amp;pages=915-925&amp;pmid=37931637&amp;doi=10.1016/S2213-8587(23)00267-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr42-19322968251362848">
<span class="label">42.</span><cite>
Galderisi A, Marks BE, DiMeglio LA, de Beaufort C. Endpoints for clinical trials in type 1 diabetes drug development. Lancet Diabetes Endocrinol. 2024;12(5):297-299. doi: 10.1016/S2213-8587(24)00097-4
</cite> [<a href="https://doi.org/10.1016/S2213-8587(24)00097-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11230104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38663944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol&amp;title=Endpoints%20for%20clinical%20trials%20in%20type%201%20diabetes%20drug%20development&amp;author=A%20Galderisi&amp;author=BE%20Marks&amp;author=LA%20DiMeglio&amp;author=C%20de%20Beaufort&amp;volume=12&amp;issue=5&amp;publication_year=2024&amp;pages=297-299&amp;pmid=38663944&amp;doi=10.1016/S2213-8587(24)00097-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr43-19322968251362848">
<span class="label">43.</span><cite>
Ramos EL, Dayan CM, Chatenoud L, et al. Teplizumab and β-cell function in newly diagnosed type 1 diabetes. N Engl J Med. 2023;389(23):2151-2161. doi: 10.1056/NEJMoa2308743
</cite> [<a href="https://doi.org/10.1056/NEJMoa2308743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37861217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Teplizumab%20and%20%CE%B2-cell%20function%20in%20newly%20diagnosed%20type%201%20diabetes&amp;author=EL%20Ramos&amp;author=CM%20Dayan&amp;author=L%20Chatenoud&amp;volume=389&amp;issue=23&amp;publication_year=2023&amp;pages=2151-2161&amp;pmid=37861217&amp;doi=10.1056/NEJMoa2308743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr44-19322968251362848">
<span class="label">44.</span><cite>
Evans-Molina C, Oram RA. A golden hour and golden opportunity for β-cell preservation. Diabetes. 2024;73(6):834-836. doi: 10.2337/dbi24-0019
</cite> [<a href="https://doi.org/10.2337/dbi24-0019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11109773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38768367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=A%20golden%20hour%20and%20golden%20opportunity%20for%20%CE%B2-cell%20preservation&amp;author=C%20Evans-Molina&amp;author=RA%20Oram&amp;volume=73&amp;issue=6&amp;publication_year=2024&amp;pages=834-836&amp;pmid=38768367&amp;doi=10.2337/dbi24-0019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr45-19322968251362848">
<span class="label">45.</span><cite>
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
</cite> [<a href="https://doi.org/10.1056/NEJM199309303291401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8366922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=The%20effect%20of%20intensive%20treatment%20of%20diabetes%20on%20the%20development%20and%20progression%20of%20long-term%20complications%20in%20insulin-dependent%20diabetes%20mellitus&amp;author=DM%20Nathan&amp;author=S%20Genuth&amp;volume=329&amp;publication_year=1993&amp;pages=977-986&amp;pmid=8366922&amp;doi=10.1056/NEJM199309303291401&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr46-19322968251362848">
<span class="label">46.</span><cite>
Dekker P, de Vries M, Aanstoot HJ, Groen J. Which C-peptide assay do you use? increasing need for describing C-peptide assay performance. Pediatr Endocrinol Diabetes Metab. 2022;28(1):101-103. doi: 10.5114/pedm.2022.113741
</cite> [<a href="https://doi.org/10.5114/pedm.2022.113741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10226358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35308000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Endocrinol%20Diabetes%20Metab&amp;title=Which%20C-peptide%20assay%20do%20you%20use?%20increasing%20need%20for%20describing%20C-peptide%20assay%20performance&amp;author=P%20Dekker&amp;author=M%20de%20Vries&amp;author=HJ%20Aanstoot&amp;author=J%20Groen&amp;volume=28&amp;issue=1&amp;publication_year=2022&amp;pages=101-103&amp;pmid=35308000&amp;doi=10.5114/pedm.2022.113741&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr47-19322968251362848">
<span class="label">47.</span><cite>
Hörber S, Orth M, Fritsche A, Peter A. Comparability of C—peptide measurements—current status and clinical relevance. Exp Clin Endocrinol Diabetes. 2023;131(3):173-178. doi: 10.1055/a-1998-6889
</cite> [<a href="https://doi.org/10.1055/a-1998-6889" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9998184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36630986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Clin%20Endocrinol%20Diabetes&amp;title=Comparability%20of%20C%E2%80%94peptide%20measurements%E2%80%94current%20status%20and%20clinical%20relevance&amp;author=S%20H%C3%B6rber&amp;author=M%20Orth&amp;author=A%20Fritsche&amp;author=A%20Peter&amp;volume=131&amp;issue=3&amp;publication_year=2023&amp;pages=173-178&amp;pmid=36630986&amp;doi=10.1055/a-1998-6889&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr48-19322968251362848">
<span class="label">48.</span><cite>
Larsen PB, Linneberg A, Hansen T, Friis-Hansen L. Reference intervals for C-peptide and insulin derived from a general adult Danish population. Clin Biochem. 2017;50(7-8):408-413. doi: 10.1016/j.clinbiochem.2016.12.004
</cite> [<a href="https://doi.org/10.1016/j.clinbiochem.2016.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27989491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Biochem&amp;title=Reference%20intervals%20for%20C-peptide%20and%20insulin%20derived%20from%20a%20general%20adult%20Danish%20population&amp;author=PB%20Larsen&amp;author=A%20Linneberg&amp;author=T%20Hansen&amp;author=L%20Friis-Hansen&amp;volume=50&amp;issue=7-8&amp;publication_year=2017&amp;pages=408-413&amp;pmid=27989491&amp;doi=10.1016/j.clinbiochem.2016.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr49-19322968251362848">
<span class="label">49.</span><cite>
Cho J, Cho HC, Ryu OH, et al. Reference standards for C-peptide in Korean population: a Korean endocrine hormone reference standard data center study. Endocrinol Metab. 2024;39(3):489-499. doi: 10.3803/EnM.2023.1888</cite> [<a href="https://doi.org/10.3803/EnM.2023.1888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11220213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38721635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinol%20Metab&amp;title=Reference%20standards%20for%20C-peptide%20in%20Korean%20population:%20a%20Korean%20endocrine%20hormone%20reference%20standard%20data%20center%20study&amp;author=J%20Cho&amp;author=HC%20Cho&amp;author=OH%20Ryu&amp;volume=39&amp;issue=3&amp;publication_year=2024&amp;pages=489-499&amp;pmid=38721635&amp;doi=10.3803/EnM.2023.1888&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr50-19322968251362848">
<span class="label">50.</span><cite>
Henny J, Vassault A, Boursier G, et al. Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med. 2016;54(12):1893-1900. doi:doi: 10.1515/cclm-2016-0793
</cite> [<a href="https://doi.org/10.1515/cclm-2016-0793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27748267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem%20Lab%20Med&amp;title=Recommendation%20for%20the%20review%20of%20biological%20reference%20intervals%20in%20medical%20laboratories&amp;author=J%20Henny&amp;author=A%20Vassault&amp;author=G%20Boursier&amp;volume=54&amp;issue=12&amp;publication_year=2016&amp;pages=1893-1900&amp;pmid=27748267&amp;doi=10.1515/cclm-2016-0793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr51-19322968251362848">
<span class="label">51.</span><cite>
Ozarda Y, Higgins V, Adeli K. Verification of reference intervals in routine clinical laboratories: practical challenges and recommendations. Clin Chem Lab Med. 2019;57(1):30-37. doi:doi: 10.1515/cclm-2018-0059</cite> [<a href="https://doi.org/10.1515/cclm-2018-0059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29729142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem%20Lab%20Med&amp;title=Verification%20of%20reference%20intervals%20in%20routine%20clinical%20laboratories:%20practical%20challenges%20and%20recommendations&amp;author=Y%20Ozarda&amp;author=V%20Higgins&amp;author=K%20Adeli&amp;volume=57&amp;issue=1&amp;publication_year=2019&amp;pages=30-37&amp;pmid=29729142&amp;doi=10.1515/cclm-2018-0059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr52-19322968251362848">
<span class="label">52.</span><cite>
Jones G, Barker A. Reference intervals. Clin Biochem Rev. 2008;29(suppl 1):S93–S97.</cite> [<a href="/articles/PMC2556592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18852866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Biochem%20Rev&amp;title=Reference%20intervals&amp;author=G%20Jones&amp;author=A%20Barker&amp;volume=29&amp;issue=suppl%201&amp;publication_year=2008&amp;pmid=18852866&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr53-19322968251362848">
<span class="label">53.</span><cite>
Wiedmeyer HM, Polonsky KS, Myers GL, et al. International comparison of C-peptide measurements. Clin Chem. 2007;53(4):784-787. doi: 10.1373/clinchem.2006.081570
</cite> [<a href="https://doi.org/10.1373/clinchem.2006.081570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17332147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=International%20comparison%20of%20C-peptide%20measurements&amp;author=HM%20Wiedmeyer&amp;author=KS%20Polonsky&amp;author=GL%20Myers&amp;volume=53&amp;issue=4&amp;publication_year=2007&amp;pages=784-787&amp;pmid=17332147&amp;doi=10.1373/clinchem.2006.081570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr54-19322968251362848">
<span class="label">54.</span><cite>
Rohlfing C, Petroski G, Connolly SM, Hanson S, Little RR, Kabytaev K. A comparative analysis of current С-peptide assays compared to a reference method: can we overcome inertia to standardization?
Clin Chem Lab Med. 2025;63:1124-1131. doi: 10.1515/cclm-2024-1260</cite> [<a href="https://doi.org/10.1515/cclm-2024-1260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12043276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39803820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem%20Lab%20Med&amp;title=A%20comparative%20analysis%20of%20current%20%D0%A1-peptide%20assays%20compared%20to%20a%20reference%20method:%20can%20we%20overcome%20inertia%20to%20standardization?&amp;author=C%20Rohlfing&amp;author=G%20Petroski&amp;author=SM%20Connolly&amp;author=S%20Hanson&amp;author=RR%20Little&amp;volume=63&amp;publication_year=2025&amp;pages=1124-1131&amp;pmid=39803820&amp;doi=10.1515/cclm-2024-1260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr55-19322968251362848">
<span class="label">55.</span><cite>
Little RR, Rohlfing CL, Tennill AL, et al. Standardization of C-peptide measurements. Clin Chem. 2008;54(6):1023-1026.
</cite> [<a href="https://doi.org/10.1373/clinchem.2007.101287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18420730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Standardization%20of%20C-peptide%20measurements&amp;author=RR%20Little&amp;author=CL%20Rohlfing&amp;author=AL%20Tennill&amp;volume=54&amp;issue=6&amp;publication_year=2008&amp;pages=1023-1026&amp;pmid=18420730&amp;doi=10.1373/clinchem.2007.101287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr56-19322968251362848">
<span class="label">56.</span><cite>
Zhou W, Deng Y, Zhao H, Zhang C. Current status of serum insulin and C-peptide measurement in clinical laboratories: experience from 94 laboratories in China. Ann Lab Med. 2022;42(4):428-437. doi: 10.3343/alm.2022.42.4.428
</cite> [<a href="https://doi.org/10.3343/alm.2022.42.4.428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8859554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35177563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Lab%20Med&amp;title=Current%20status%20of%20serum%20insulin%20and%20C-peptide%20measurement%20in%20clinical%20laboratories:%20experience%20from%2094%20laboratories%20in%20China&amp;author=W%20Zhou&amp;author=Y%20Deng&amp;author=H%20Zhao&amp;author=C%20Zhang&amp;volume=42&amp;issue=4&amp;publication_year=2022&amp;pages=428-437&amp;pmid=35177563&amp;doi=10.3343/alm.2022.42.4.428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr57-19322968251362848">
<span class="label">57.</span><cite>
Tim Cao Z, Rej R, Vesper H, Rex Astles J. Accuracy-based proficiency testing for estradiol measurements. Clin Biochem. 2024;124:110700. doi: 10.1016/j.clinbiochem.2023.110700
</cite> [<a href="https://doi.org/10.1016/j.clinbiochem.2023.110700" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11261451/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38043696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Biochem&amp;title=Accuracy-based%20proficiency%20testing%20for%20estradiol%20measurements&amp;author=Z%20Tim%20Cao&amp;author=R%20Rej&amp;author=H%20Vesper&amp;author=J%20Rex%20Astles&amp;volume=124&amp;publication_year=2024&amp;pages=110700&amp;pmid=38043696&amp;doi=10.1016/j.clinbiochem.2023.110700&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr58-19322968251362848">
<span class="label">58.</span><cite>
Cowper B, Lyle AN, Vesper HW, Uytfanghe KV, Burns C. Standardisation and harmonisation of thyroid-stimulating hormone measurements: historical, current, and future perspectives. Clin Chem Lab Med. 2024;62(5):824-829. doi: 10.1515/cclm-2023-1332
</cite> [<a href="https://doi.org/10.1515/cclm-2023-1332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38295422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem%20Lab%20Med&amp;title=Standardisation%20and%20harmonisation%20of%20thyroid-stimulating%20hormone%20measurements:%20historical,%20current,%20and%20future%20perspectives&amp;author=B%20Cowper&amp;author=AN%20Lyle&amp;author=HW%20Vesper&amp;author=KV%20Uytfanghe&amp;author=C%20Burns&amp;volume=62&amp;issue=5&amp;publication_year=2024&amp;pages=824-829&amp;pmid=38295422&amp;doi=10.1515/cclm-2023-1332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bibr59-19322968251362848">
<span class="label">59.</span><cite>
Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47.
</cite> [<a href="https://doi.org/10.1186/1472-6823-13-47" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4016563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24131857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Endocr%20Disord&amp;title=Insulin%20resistance%20(HOMA-IR)%20cut-off%20values%20and%20the%20metabolic%20syndrome%20in%20a%20general%20adult%20population:%20effect%20of%20gender%20and%20age:%20EPIRCE%20cross-sectional%20study&amp;author=P%20Gayoso-Diz&amp;author=A%20Otero-Gonz%C3%A1lez&amp;author=MX%20Rodriguez-Alvarez&amp;volume=13&amp;publication_year=2013&amp;pages=47&amp;pmid=24131857&amp;doi=10.1186/1472-6823-13-47&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Diabetes Science and Technology are provided here courtesy of <strong>Diabetes Technology Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1177/19322968251362848"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/10.1177_19322968251362848.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (437.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12335430/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12335430/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12335430%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12335430/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12335430/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12335430/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40781799/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12335430/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40781799/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12335430/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12335430/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="gkZ1HKRFI4TK4jcnDjHsMOUTtdRyuCELkfA2p8KVtaEwIECfIViMpwEiBnrtA8BQ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
